Anticancer activity of new cationic arylthiophenes against hepatocellular carcinoma

Al-Shun, Sara A; El-Senduny, Fardous F; Ismail, Mohamed A; El-Sayed, Wael; Badria, Farid A; Youssef, Magdy M;

Abstract


Hepatocellular carcinoma (HCC) is the second most common cancer-related death in the world. No effective curative option exists for the treatment of HCC. The available drugs exhibit severe toxic effects and low therapeutic index.


Other data

Title Anticancer activity of new cationic arylthiophenes against hepatocellular carcinoma
Authors Al-Shun, Sara A; El-Senduny, Fardous F; Ismail, Mohamed A ; El-Sayed, Wael ; Badria, Farid A; Youssef, Magdy M 
Keywords Apoptosis induction;Arylthiophenes;Hepatocellular carcinoma;p53 activation
Issue Date 15-Mar-2021
Publisher PERGAMON-ELSEVIER SCIENCE LTD
Journal Life Science Journal 
Volume 269
ISSN 0024-3205
DOI 10.1016/j.lfs.2021.119028
PubMed ID 33444618
Scopus ID 2-s2.0-85099608388
Web of science ID WOS:000616196300019

Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

Citations 1 in pubmed
Citations 8 in scopus


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.